Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 82
Selected: 0
NCT IDTitle
NCT05193604A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma
NCT06948539To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
NCT07653685A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
NCT05493995A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
NCT05494060XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT07179679A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT01833923A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics
NCT06977750Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection
NCT06230588A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
NCT07177859A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT06700395A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT06451640A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps
NCT05380882Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers
NCT06558656Effect of Food of NTQ5082 in Healthy Subjects
NCT07008976Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer
NCT07047365TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT06115902A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
NCT07177872A Long-term Efficacy and Safety of NTQ5082 Capsules
NCT06172309A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors
NCT06188624Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
NCT01959061Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases
NCT05192512Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT06569524Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
NCT07043751A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
NCT06982040Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy
NCT06438783TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors
NCT06798207A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
NCT06962267A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT06449859A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects
NCT06977763Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection
NCT06929195Clinical Trial to Evaluate the Tolerance of TQB2210 Injection
NCT05450887Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
NCT05867563Clinical Trial Evaluating the Safety of the TQB2103 for Injection
NCT06560593A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers
NCT06585059Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
NCT05045872Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT06106841TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
NCT06767800A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma
NCT06767813Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
NCT06496490A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
NCT06754891Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
NCT07003074A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
NCT05213767Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors
NCT07113925A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
NCT05032937the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
NCT02136992Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
NCT06143423A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
NCT06431490A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT07044908TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer